Advertisement

Transcriptome Sequencing (RNA-Seq)

  • Sugganth Daniel
  • Alberto Paniz-Mondolfi
  • Federico A. Monzon
Chapter

Abstract

The transcriptome is the entire assembly of RNA transcripts in a given cell type, including protein coding and noncoding transcripts. Transcriptome sequencing (RNA-Seq) is a recently developed technology that uses high-throughput sequencing approaches (next-generation sequencing or NGS) to determine the sequence of all RNA transcripts in a given specimen. This chapter provides an overview of the development and technical background of transcriptomics and the advantages and limitations of RNA-Seq. This technology has rapidly increased our understanding of gene expression profiles of various cells and tissues and is allowing us to better understand alternative splicing and the functional elements of the genome, and to identify new fusion transcripts in cancer. We also review research and potential clinical applications of RNA-Seq technology in inherited, chronic, neoplastic, and infectious diseases.

Keywords

Down Syndrome Fanconi Anemia Transcriptome Profile Fusion Transcript Massively Parallel Signature Sequencing 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Piétu G, Mariage-Samson R, Fayein NA, Matingou C, Eveno E, Houlgatte R, et al. The Genexpress IMAGE knowledge base of the human brain transcriptome: a prototype integrated resource for functional and computational genomics. Genome Res. 1999;9(2):195–209.PubMedPubMedCentralGoogle Scholar
  2. 2.
    Ozsolak F, Milos PM. RNA sequencing: advances, challenges and opportunities. Nat Rev Genet. 2011;12:87–98 (Review on RNA-Seq).PubMedPubMedCentralGoogle Scholar
  3. 3.
    Morozova O, Hirst M, Marra MA. Applications of new sequencing technologies for transcriptome analysis. Annu Rev Genomics Hum Genet. 2009;10:135–51.PubMedGoogle Scholar
  4. 4.
    Shah SP, Köbel M, Senz J, Morin RD, Clarke BA, Wiegand KC, Leung G, Zayed A, et al. Mutation of FOXL2 in granulosa-cell tumors of the ovary. N Engl J Med. 2009;360(26):2719–29 (RNA-Seq for fusion transcripts).PubMedGoogle Scholar
  5. 5.
    Wang Z, Gerstein M, Snyder M. RNA-Seq: a revolutionary tool for transcriptomics. Nat Rev Genet. 2009;10(1):57–63 (Review on RNA-Seq).PubMedPubMedCentralGoogle Scholar
  6. 6.
    Collisson EA, Cho RJ, Gray JW. What are we learning from the cancer genome? Nat Rev Clin Oncol. 2012;9(11):621–30 (Review on NGS in cancer).PubMedGoogle Scholar
  7. 7.
    Schena M, Shalon D, Davis RW, Brown PO. Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science. 1995;270:467–70.PubMedGoogle Scholar
  8. 8.
    Golub TR, Slonim DK, Tamayo P, Huard C, Gaasenbeek M, Mesirov JP, et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science. 1999;286:531–7.PubMedGoogle Scholar
  9. 9.
    Monzon FA, Lyons-Weiler M, Buturovic LJ, Rigl CT, Henner WD, Sciulli CM, Dumur CI, Medeiros F, Anderson GG. Clinical validation of a gene expression test for identification of tumor tissue of origin. J Clin Oncol. 2009;27(15):2503–8.PubMedGoogle Scholar
  10. 10.
    Shi L, Reid LH, Jones WD, Shippy R, Warrington JA, Baker SC, et al. The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements. Nat Biotechnol. 2006;24:1151–61.PubMedGoogle Scholar
  11. 11.
    Malone JH, Oliver B. Microarrays, deep sequencing and the true measure of the transcriptome. BMC Biol. 2011;9:34 (Review on Microarrays and RNA-Seq).PubMedPubMedCentralGoogle Scholar
  12. 12.
    Perou CM, Sørlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, et al. Molecular portraits of human breast tumours. Nature. 2000;406(6797):747–52.PubMedGoogle Scholar
  13. 13.
    Yeoh EJ, Ross ME, Shurtleff SA, Williams WK, Patel D, Mahfouz R, et al. Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling. Cancer Cell. 2002;1(2):133–43.PubMedGoogle Scholar
  14. 14.
    Alizadeh AA, Eisen MB, Davis RE, Ma C, Lossos IS, Rosenwald A, et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature. 2000;403(6769):503–11.PubMedGoogle Scholar
  15. 15.
    Sharov V, Kwong KY, Frank B, Chen E, Hasseman J, Gaspard R, Yu Y, Yang I, Quackenbush J. The limits of log-ratios. BMC Biotechnol. 2004;4:3.PubMedPubMedCentralGoogle Scholar
  16. 16.
    Harbers M, Carninci P. Tag-based approaches for transcriptome research and genome annotation. Nat Methods. 2005;2:495–502.PubMedGoogle Scholar
  17. 17.
    Bertone P, Stolc V, Royce TE, Rozowsky JS, Urban AE, Zhu X, et al. Global identification of human transcribed sequences with genome tiling arrays. Science. 2004;306:2242–6.PubMedGoogle Scholar
  18. 18.
    Marioni JC, Mason CE, Mane SM, Stephens M, Gilad Y. RNA-seq: an assessment of technical reproducibility and comparison with gene expression arrays. Genome Res. 2008;18:1509–17.PubMedPubMedCentralGoogle Scholar
  19. 19.
    Bradford JR, Hey Y, Yates T, Li Y, Pepper SD, Miller CJ. A comparison of massively parallel nucleotide sequencing with oligonucleotide microarrays for global transcription profiling. BMC Genomics. 2010;11:282.PubMedPubMedCentralGoogle Scholar
  20. 20.
    Metzker ML. Sequencing technologies—the next generation. Nat Rev Genet. 2010;11:31–46 (Excellent review on sequencing platforms).PubMedGoogle Scholar
  21. 21.
    Lee H, Tang H. Next generation sequencing technologies and fragment assembly algorithms. Methods Mol Biol. 2012;855:155–74.PubMedGoogle Scholar
  22. 22.
    Glenn TC. Field guide to next-generation DNA sequencers. Mol Ecol Resour. 2011;11(5):759–69.PubMedGoogle Scholar
  23. 23.
    Rothberg JM, Leamon JH. The development and impact of 454 sequencing. Nat Biotechnol. 2008;26(10):1117–24.PubMedGoogle Scholar
  24. 24.
    Leamon JH, Lee WL, Tartaro KR, Lanza JR, Sarkis GJ, deWinter AD, et al. A massively parallel PicoTiterPlate based platform for discrete picoliter-scale polymerase chain reactions. Electrophoresis. 2003;24:3769–77 (Roche 454).PubMedGoogle Scholar
  25. 25.
    Valouev A, Ichikawa J, Tonthat T, Stuart J, Ranade S, Peckham H, et al. A high-resolution, nucleosome position map of C. elegans reveals a lack of universal sequence-dictated positioning. Genome Res. 2008;18:1051–63.PubMedPubMedCentralGoogle Scholar
  26. 26.
    Bentley DR, Balasubramanian S, Swerdlow HP, Smith GP, Milton J, Brown CG, et al. Accurate whole human genome sequencing using reversible terminator chemistry. Nature. 2008;456:53–9.PubMedPubMedCentralGoogle Scholar
  27. 27.
    Rothberg JM, Hinz W, Rearick TM, Schultz J, Mileski W, Davey M, et al. An integrated semiconductor device enabling non-optical genome sequencing. Nature. 2011;475(7356):348–52.PubMedGoogle Scholar
  28. 28.
    Sam LT, Lipson D, Raz T, Cao X, Thompson J, Milos PM, et al. A comparison of single molecule and amplification based sequencing of cancer transcriptomes. PLoS One. 2011;6(3):e17305.PubMedPubMedCentralGoogle Scholar
  29. 29.
    Harris TD, Buzby PR, Babcock H, Beer E, Bowers J, Braslavsky I, et al. Single-molecule DNA sequencing of a viral genome. Science. 2008;320:106–9.PubMedGoogle Scholar
  30. 30.
    Eid J, Fehr A, Gray J, Luong K, Lyle J, Otto G, et al. Real-time DNA sequencing from single polymerase molecules. Science. 2009;323:133–8.PubMedGoogle Scholar
  31. 31.
    Morin R, Bainbridge M, Fejes A, Hirst M, Krzywinski M, Pugh T, et al. Profiling the HeLa S3 transcriptome using randomly primed cDNA and massively parallel short-read sequencing. Biotechniques. 2008;45(1):81–94. doi: 10.2144/000112900.PubMedGoogle Scholar
  32. 32.
    Nagalakshmi U, Waern K, Snyder M. RNA-Seq: a method for comprehensive transcriptome analysis. Curr Protoc Mol Biol. 2010;Chapter 4:Unit 4.11.1-13.Google Scholar
  33. 33.
    He S, Wurtzel O, Singh K, Froula JL, Yilmaz S, Tringe SG, et al. Validation of two ribosomal RNA removal methods for microbial metatranscriptomics. Nat Methods. 2010;7:807–12.PubMedGoogle Scholar
  34. 34.
    Martin JA, Wang Z. Next-generation transcriptome assembly. Nat Rev Genet. 2011;12(10):671–82.PubMedGoogle Scholar
  35. 35.
    Rodrigue S, Materna AC, Timberlake SC, Blackburn MC, Malmstrom RR, Alm EJ, et al. Unlocking short read sequencing for metagenomics. PLoS One. 2010;5:e11840.PubMedPubMedCentralGoogle Scholar
  36. 36.
    Falgueras J, Lara AJ, Fernández-Pozo N, Cantón FR, Pérez-Trabado G, Claros MG. SeqTrim: a high-throughput pipeline for pre-processing any type of sequence read. BMC Bioinformatics. 2010;11:38.PubMedPubMedCentralGoogle Scholar
  37. 37.
    Lassmann T, Hayashizaki Y, Daub CO. TagDust—a program to eliminate artifacts from next generation sequencing data. Bioinformatics. 2009;25:2839–40.PubMedPubMedCentralGoogle Scholar
  38. 38.
    Kent WJ. BLAT-the BLAST-like alignment tool. Genome Res. 2002;12:656–64.PubMedPubMedCentralGoogle Scholar
  39. 39.
    Trapnell C, Pachter L, Salzberg SL. TopHat: discovering splice junctions with RNA-seq. Bioinformatics. 2009;25:1105–11.PubMedPubMedCentralGoogle Scholar
  40. 40.
    Trapnell C, Williams BA, Pertea G, Mortazavi A, Kwan G, van Baren MJ, et al. Transcript assembly and quantification by RNA-seq reveals unannotated transcripts and isoform switching during cell differentiation. Nat Biotechnol. 2010;28:511–5.PubMedPubMedCentralGoogle Scholar
  41. 41.
    Grabherr MG, Haas BJ, Yassour M, Levin JZ, Thompson DA, Amit I, et al. Full-length transcriptome assembly from RNA-seq data without a reference genome. Nat Biotechnol. 2011;29:644–52.PubMedPubMedCentralGoogle Scholar
  42. 42.
    Iyer MK, Chinnaiyan AM. RNA-Seq unleashed. Nat Biotechnol. 2011;29(7):599–600.PubMedGoogle Scholar
  43. 43.
    Faghihi MA, Wahlestedt C. Regulatory roles of natural antisense transcripts. Nat Rev Mol Cell Biol. 2009;10:637–43.PubMedPubMedCentralGoogle Scholar
  44. 44.
    Levin JZ, Yassour M, Adiconis X, Nusbaum C, Thompson DA, Friedman N, et al. Comprehensive comparative analysis of strand-specific RNA sequencing methods. Nat Methods. 2010;7:709–15.PubMedPubMedCentralGoogle Scholar
  45. 45.
    Levin JZ, Berger MF, Adiconis X, Rogov P, Melnikov A, Fennell T, et al. Targeted next-generation sequencing of a cancer transcriptome enhances detection of sequence variants and novel fusion transcripts. Genome Biol. 2009;10:R115.PubMedPubMedCentralGoogle Scholar
  46. 46.
    Nikiforov YE, Yip L, Nikiforova MN. New strategies in diagnosing cancer in thyroid nodules: impact of molecular markers. Clin Cancer Res. 2013;19(9):2283–8. 46.PubMedGoogle Scholar
  47. 47.
    Ozsolak F, Platt AR, Jones DR, Reifenberger JG, Sass LE, McInerney P, et al. Direct RNA sequencing. Nature. 2009;461:814–8.PubMedGoogle Scholar
  48. 48.
    Ozsolak F. Third-generation sequencing techniques and applications to drug discovery. Expert Opin Drug Discov. 2012;7(3):231–43.PubMedPubMedCentralGoogle Scholar
  49. 49.
    Prat A, Ellis MJ, Perou CM. Practical implications of gene-expression-based assays for breast oncologists. Nat Rev Clin Oncol. 2011;9(1):48–57.PubMedPubMedCentralGoogle Scholar
  50. 50.
    Baehner FL, Lee M, Demeure MJ, Bussey KJ, Kiefer JA, Barrett MT. Genomic signatures of cancer: basis for individualized risk assessment, selective staging and therapy. J Surg Oncol. 2011;103(6):563–73.PubMedGoogle Scholar
  51. 51.
    Chibon F. Cancer gene expression signatures—the rise and fall? Eur J Cancer. 2013;49(8):2000–9.PubMedGoogle Scholar
  52. 52.
    Pham MX, Teuteberg JJ, Kfoury AG, et al. Gene-expression profiling for rejection surveillance after cardiac transplantation. N Engl J Med. 2010;20:1890–900.Google Scholar
  53. 53.
    Cooper-Knock J, Kirby J, Ferraiuolo L, Heath PR, Rattray M, Shaw PJ. Gene expression profiling in human neurodegenerative disease. Nat Rev Neurol. 2012;8(9):518–30. doi: 10.1038/nrneurol.2012.156. Epub 2012 Aug 14.PubMedGoogle Scholar
  54. 54.
    Drew JE. Cellular defense system gene expression profiling of human whole blood: opportunities to predict health benefits in response to diet. Adv Nutr. 2012;3(4):499–505.PubMedPubMedCentralGoogle Scholar
  55. 55.
    Shih B, Watson S, Bayat A. Whole genome and global expression profiling of Dupuytren’s disease: systematic review of current findings and future perspectives. Ann Rheum Dis. 2012;71(9):1440–7. doi: 10.1136/annrheumdis-2012-201295. Epub 2012 Jul 6.PubMedGoogle Scholar
  56. 56.
    Meldrum C, Doyle MA, Tothill RW. Next-generation sequencing for cancer diagnostics: a practical perspective. Clin Biochem Rev. 2011;32:177–95.PubMedPubMedCentralGoogle Scholar
  57. 57.
    Saunders CJ, Miller NA, Soden SE, et al. Rapid whole-genome sequencing for genetic disease diagnosis in neonatal intensive care units. Sci Transl Med. 2012;4:154ra135.PubMedGoogle Scholar
  58. 58.
    Pagon RA, Adam MP, Bird TD, Dolan CR, Fong CT, Stephens K, editors. GeneReviews™ [Internet]. Seattle, WA: University of Washington, Seattle; 1993–2013. http://www.ncbi.nlm.nih.gov/books/NBK1116/
  59. 59.
    Xue Y, Chen Y, Ayub Q, Huang N, Ball EV, Mort M, Phillips AD, Shaw K, Stenson PD, Cooper DN, Tyler-Smith C, the 1000 Genomes Project Consortium. Deleterious- and disease-allele prevalence in healthy individuals: insights from current predictions, mutation databases, and population-scale resequencing. Am J Hum Genet. 2012;91:1022–32.PubMedPubMedCentralGoogle Scholar
  60. 60.
    Naidoo N, Pawitan Y, Soong R, Cooper DN, Ku CS. Human genetics and genomics a decade after the release of the draft sequence of the human genome. Hum Genomics. 2011;5(6):577–622.PubMedPubMedCentralGoogle Scholar
  61. 61.
    Teekakirikul P, Kelly MA, Rehm HL, Lakdawala NK, Funke BH. Inherited cardiomyopathies: molecular genetics and clinical genetic testing in the postgenomic era. J Mol Diagn. 2013;15(2):158–70.PubMedGoogle Scholar
  62. 62.
    Mayer AN, Dimmock DP, Arca MJ, Bick DP, Verbsky JW, Worthey EA, Jacob HJ, Margolis DA. A timely arrival for genomic medicine. Genet Med. 2011;13(3):195–6.PubMedGoogle Scholar
  63. 63.
    Schrijver I, Aziz N, Farkas DH, et al. Opportunities and challenges associated with clinical diagnostic genome sequencing: a report of the Association for Molecular Pathology. J Mol Diagn. 2012;14(6):525–40.PubMedGoogle Scholar
  64. 64.
    Chandrasekharappa SC, Lach FP, Kimble DC, Kamat A, Teer JK, Donovan FX, NISC Comparative Sequencing Program, et al. Massively parallel sequencing, aCGH, and RNA-Seq technologies provide a comprehensive molecular diagnosis of Fanconi anemia. Blood. 2013;121(22):e138–48.PubMedPubMedCentralGoogle Scholar
  65. 65.
    Costa V, Angelini V, D’Apice L, Mutarelli M, Casanassimi A, et al. Massive-scale RNA-Seq analysis of non ribosomal transcriptome in human trisomy 21. PLoS One. 2011;6(4):e18493.PubMedPubMedCentralGoogle Scholar
  66. 66.
    Freedman ML, Monteiro AN, Gayther SA, et al. Principles for the post-GWAS functional characterization of cancer risk loci. Nat Genet. 2011;43:513–21.PubMedPubMedCentralGoogle Scholar
  67. 67.
    Costa V, Aprile M, Esposito R, Ciccodicola A. RNA-Seq and human complex diseases: recent accomplishments and future perspectives. Eur J Hum Genet. 2013;21(2):134–42.PubMedPubMedCentralGoogle Scholar
  68. 68.
    Majewski J, Pastinen T. The study of eQTL variations by RNA-seq: from SNPs to phenotypes. Trends Genet. 2011;27(2):72–9.PubMedGoogle Scholar
  69. 69.
    Musunuru K, Strong A, Frank-Kamenetsky M, Lee NE, Ahfeldt T, Sachs KV, et al. From noncoding variant to phenotype via SORT1 at the 1p13 cholesterol locus. Nature. 2010;466(7307):714–9. doi: 10.1038/nature09266.PubMedPubMedCentralGoogle Scholar
  70. 70.
    Kalyana-Sundaram S, Kumar-Sinha C, Shankar S, Robinson DR, Wu YM, Cao X, et al. Expressed pseudogenes in the transcriptional landscape of human cancers. Cell. 2012;149(7):1622–34.PubMedPubMedCentralGoogle Scholar
  71. 71.
    Monzon FA, Koen TJ. Diagnosis of metastatic neoplasms: molecular approaches for identification of tissue of origin. Arch Pathol Lab Med. 2010;134(2):216–24.PubMedGoogle Scholar
  72. 72.
    Erlander MG, Ma XJ, Kesty NC, Bao L, Salunga R, Schnabel CA. Performance and clinical evaluation of the 92-gene real-time PCR assay for tumor classification. J Mol Diagn. 2011;13(5):493–503. doi: 10.1016/j.jmoldx.2011.04.004. Epub 2011 Jun 25.PubMedPubMedCentralGoogle Scholar
  73. 73.
    Varadhachary G. New strategies for carcinoma of unknown primary: the role of tissue-of-origin molecular profiling. Clin Cancer Res. 2013;19(15):4027–33.PubMedGoogle Scholar
  74. 74.
    Ramsköld D, Luo S, Wang YC, Li R, Deng Q, Faridani OR, et al. Full-length mRNA-Seq from single-cell levels of RNA and individual circulating tumor cells. Nat Biotechnol. 2012;30(8):777–82.PubMedPubMedCentralGoogle Scholar
  75. 75.
    Sinicropi D, Qu K, Collin F, Crager M, Liu ML, Pelham RJ, et al. Whole transcriptome RNA-Seq analysis of breast cancer recurrence risk using formalin-fixed paraffin-embedded tumor tissue. PLoS One. 2012;7(7):e40092.PubMedPubMedCentralGoogle Scholar
  76. 76.
    Tomlins SA, Rhodes DR, Perner S, et al. Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science. 2005;310:644–8.PubMedGoogle Scholar
  77. 77.
    Santoro M, Melillo RM, Fusco A. RET/PTC activation in papillary thyroid carcinoma: European Journal of Endocrinology Prize Lecture. Eur J Endocrinol. 2006;155:645–53.PubMedGoogle Scholar
  78. 78.
    Soda M, Choi YL, Enomoto M, Takada S, Yamashita Y, Ishikawa S, et al. Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer. Nature. 2007;448:561–6.PubMedGoogle Scholar
  79. 79.
    Maher CA, Kumar-Sinha C, Cao X, Kalyana-Sundaram S, Han B, Jing X, Sam L, Barrette T, Palanisamy N, Chinnaiyan AM. Transcriptome sequencing to detect gene fusions in cancer. Nature. 2009;458(7234):97–101.PubMedPubMedCentralGoogle Scholar
  80. 80.
    Edgren H, Murumagi A, Kangaspeska S, Nicorici D, Hongisto V, Kleivi K, Rye IH, Nyberg S, Wolf M, Borresen-Dale AL, Kallioniemi O. Identification of fusion genes in breast cancer by paired-end RNA-sequencing. Genome Biol. 2011;12(1):R6.PubMedPubMedCentralGoogle Scholar
  81. 81.
    Robinson DR, Kalyana-Sundaram S, Wu YM, Shankar S, Cao X, Ateeq B, et al. Functionally recurrent rearrangements of the MAST kinase and Notch gene families in breast cancer. Nat Med. 2011;17:1646–51.PubMedPubMedCentralGoogle Scholar
  82. 82.
    Seshagiri S, Stawiski EW, Durinck S, Modrusan Z, Storm EE, Conboy CB, et al. Recurrent R-spondin fusions in colon cancer. Nature. 2012;488:660–4.PubMedPubMedCentralGoogle Scholar
  83. 83.
    Wu YM, Su F, Kalyana-Sundaram S, Khazanov N, Ateeq B, Cao X, et al. Identification of targetable FGFR gene fusions in diverse cancers. Cancer Discov. 2013;3(6):636–47.PubMedPubMedCentralGoogle Scholar
  84. 84.
    Lindeman NI, Cagle PT, Beasley MB, Chitale DA, Dacic S, Giaccone G, et al. Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology. J Mol Diagn. 2013;15(4):415–53.PubMedGoogle Scholar
  85. 85.
    Kwak EL, Bang YJ, Camidge DR, Shaw AT, Solomon B, Maki RG, et al. Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer. N Engl J Med. 2010;363(18):1693–703. doi: 10.1056/NEJMoa1006448.PubMedPubMedCentralGoogle Scholar
  86. 86.
    Wen H, Li Y, Malek SN, Kim YC, Xu J, Chen P, et al. New fusion transcripts identified in normal karyotype acute myeloid leukemia. PLoS One. 2012;7(12):e51203. doi: 10.1371/journal.pone.0051203. Epub 2012 Dec 12.PubMedPubMedCentralGoogle Scholar
  87. 87.
    Zhou JB, Zhang T, Wang BF, Gao HZ, Xu X. Identification of a novel gene fusion RNF213-SLC26A11 in chronic myeloid leukemia by RNA-Seq. Mol Med Rep. 2013;7(2):591–7. doi: 10.3892/mmr.2012.1183.PubMedGoogle Scholar
  88. 88.
    Kolata G. In leukemia treatment, glimpses of the future. The New York Times. July 8, 2012; A1.Google Scholar
  89. 89.
    Roychowdhury S, Iyer MK, Robinson DR, Lonigro RJ, Wu YM, Cao X, et al. Personalized oncology through integrative high-throughput sequencing: a pilot study. Sci Transl Med. 2011;3:111ra21.Google Scholar
  90. 90.
    Shah P, Morin RD, Khattra J, Prentice L, Pugh T, Burleigh A, Delaney A, Gelmon K, Guliany R, Senz J, et al. Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution. Nature. 2009;461:809–13.PubMedGoogle Scholar
  91. 91.
    Gerlinger M, Rowan AJ, Horswell S, Larkin J, Endesfelder D, Gronroos E, et al. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N Engl J Med. 2012;366(10):883–92.PubMedGoogle Scholar
  92. 92.
    Sottoriva A, Spiteri I, Piccirillo SG, Touloumis A, Collins VP, Marioni JC, Curtis C, Watts C, Tavaré S. Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics. Proc Natl Acad Sci U S A. 2013;110(10):4009–14.PubMedPubMedCentralGoogle Scholar
  93. 93.
    Stevens JB, Horne SD, Abdallah BY, Ye CJ, Heng HH. Chromosomal instability and transcriptome dynamics in cancer. Cancer Metastasis Rev. 2013;32(3–4):391–402.PubMedGoogle Scholar
  94. 94.
    Dienstmann R, Rodon J, Barretina J, Tabernero J. Genomic medicine frontier in human solid tumors: prospects and challenges. J Clin Oncol. 2013;31(15):1874–84.PubMedGoogle Scholar
  95. 95.
    Mardis ER. Applying next-generation sequencing to pancreatic cancer treatment. Nat Rev Gastroenterol Hepatol. 2012;9:477–86.PubMedGoogle Scholar
  96. 96.
    Downing JR, Wilson RK, Zhang J, Mardis ER, Pui CH, Ding L, Ley TJ, Evans WE. The pediatric cancer genome project. Nat Genet. 2012;44(6):619–22.PubMedPubMedCentralGoogle Scholar
  97. 97.
    Human Microbiome Project Consortium. Structure, function and diversity of the healthy human microbiome. Nature. 2012;486(7402):207–14.Google Scholar
  98. 98.
    Li E, Hamm CM, Gulati AS, Sartor RB, Chen H, Wu X, et al. Inflammatory bowel diseases phenotype, C. difficile and NOD2 genotype are associated with shifts in human ileum associated microbial composition. PLoS One. 2012;7(6):e26284.PubMedPubMedCentralGoogle Scholar
  99. 99.
    Woo PC, Lau SK, Teng JL, Tse H, Yuen KY. Then and now: use of 16S rDNA gene sequencing for bacterial identification and discovery of novel bacteria in clinical microbiology laboratories. Clin Microbiol Infect. 2008;14(10):908–34.PubMedGoogle Scholar
  100. 100.
    Croucher NJ, Thomson NR. Studying bacterial transcriptomes using RNA-seq. Curr Opin Microbiol. 2010;13(5):619–24.PubMedPubMedCentralGoogle Scholar
  101. 101.
    Pinto AC, Melo-Barbosa HP, Miyoshi A, Silva A, Azevedo V. Application of RNA-seq to reveal the transcript profile in bacteria. Genet Mol Res. 2011;10(3):1707–18.PubMedGoogle Scholar
  102. 102.
    Güell M, Yus E, Lluch-Senar M, Serrano L. Bacterial transcriptomics: what is beyond the RNA horiz-ome? Nat Rev Microbiol. 2011;9(9):658–69. doi: 10.1038/nrmicro2620.PubMedGoogle Scholar
  103. 103.
    van Vliet AHM. Next generation sequencing of microbial transcriptomes: challenges and opportunities. FEMS Microbiol Lett. 2010;302:1–7.PubMedGoogle Scholar
  104. 104.
    Passalacqua KD, Varadarajan A, Ondov BD, Okou DT, Zwick ME, Bergman NH. Structure and complexity of a bacterial transcriptome. J Bacteriol. 2009;191:3203–11.PubMedPubMedCentralGoogle Scholar
  105. 105.
    Deutscher MP. Degradation of stable RNA in bacteria. J Biol Chem. 2003;278:45041–4.PubMedGoogle Scholar
  106. 106.
    Condon C. Maturation and degradation of RNA in bacteria. Curr Opin Microbiol. 2007;10:271–8.PubMedGoogle Scholar
  107. 107.
    Yoder-Himes DR, Chain PS, Zhu Y, Wurtzel O, Rubin EM, Tiedje JM, Sorek R. Mapping the Burkholderia cenocepacia niche response via high-throughput sequencing. Proc Natl Acad Sci U S A. 2009;106:3976–81.PubMedPubMedCentralGoogle Scholar
  108. 108.
    Perkins TT, Kingsley RA, Fookes MC, et al. A strand-specific RNA-seq analysis of the transcriptome of the typhoid bacillus Salmonella typhi. PLoS Genet. 2009;5:e1000569.PubMedPubMedCentralGoogle Scholar
  109. 109.
    Pallen MJ, Loman NJ, Penn CW. High-throughput sequencing and clinical microbiology: progress, opportunities and challenges. Curr Opin Microbiol. 2012;13:625–31.Google Scholar
  110. 110.
    Sorek R, Cossart P. Prokaryotic transcriptomics: a new view on regulation, physiology and pathogenicity. Nat Rev Genet. 2010;11:9–16.PubMedGoogle Scholar
  111. 111.
    Toledo-Arana A, Dussurget O, Nikitas G, Sesto N, Guet-Revillet H, Balestrino D, et al. The Listeria transcriptional landscape from saprophytism to virulence. Nature. 2009;459(7249):950–6. doi: 10.1038/nature08080. Epub 2009 May 17.PubMedGoogle Scholar
  112. 112.
    Sharma CM, Hoffmann S, Darfeuille F, Reignier J, et al. The primary transcriptome of the major human pathogen Helicobacter pylori. Nature. 2010;464:250–5.PubMedGoogle Scholar
  113. 113.
    Westermann AJ, Gorski SA, Vogel J. Dual RNA-seq of pathogen and host. Nat Rev Microbiol. 2012;10:618–30.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2015

Authors and Affiliations

  • Sugganth Daniel
    • 1
  • Alberto Paniz-Mondolfi
    • 1
  • Federico A. Monzon
    • 1
    • 2
  1. 1.Department of Pathology and ImmunologyBaylor College of MedicineHoustonUSA
  2. 2.Department of Molecular and Human GeneticsBaylor College of MedicineHoustonUSA

Personalised recommendations